Department of Bioengineering and Therapeutic Sciences

The implantable bioartificial kidney is explained in this December 6, 2010, SmartPlanet video featuring Shuvo Roy, PhD, a faculty member in the UCSF Schools of Pharmacy and Medicine.

Shuvo Roy, PhD, an engineer and research scientist, is leading a U.S. project to build the world’s first bioartificial kidney to treat end stage renal disease. The goal is to surgically implant this coffee-cup-sized device in a human patient within 5 to 7 years.

Paul Ortiz de Montellano, PhD, is the newly appointed associate dean of research in the UCSF School of Pharmacy.

Kathy Giacomini, PhD, co-chair of the Department of Bioengineering and Therapeutic Sciences, UCSF Schools of Pharmacy and Medicine, will receive the 2010 Therapeutic Frontiers Lecture Award from the American College of Clinical Pharmacy on October 17, 2010, in Austin, Texas at

UCSF, Harvard University, and Stanford University have been ranked as the top three world universities in the broad subject fields of clinical medicine and pharmacy in the 2010 Academic Ranking of World Universities (ARWU), which was released on August 15, 2010, by the Center

A national research project is under way to develop an surgically implantable bioartificial kidney using the latest advances in science and technology with the goal of both improving the health and lives of patients with end stage renal disease and saving health care dollars.

Michael Fischbach, PhD, is the recipient of a 2010 NIH Director’s New Innovator Award from the National Institutes of Health.

Fresh UCSF Leadership: Desmond-Hellmann, Bluestone, Plotts, Harel, Moss, Hawgood, Featherstone; Leadership Transitions: Debas, Feachem, Dracup; UCSF Economic Impact Report; UCSF Operations and Budget Cuts: 3 campus work groups, 3 fiscal challenges, $28 million cut; UCSF Physical and Program Plans:...

Kathy Giacomini, PhD, co-chair of the UCSF Department of Bioengineering and Therapeutic Sciences and an expert in the field of pharmacogenomics, is leading two research projects funded by two grants totaling $15.1 million over the next five years to expand research into how ge

The model for a surgically implantable bioartificial kidney the size of a coffee cup has been unveiled by the national project's lead researcher, Shuvo Roy, PhD, a member of the UCSF Department of Bioengineering and Therapeutic Sciences.